⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604)

Official Title: A Phase 3 Randomized, Double-Blind, Placebo-controlled Trial of Pembrolizumab (MK-3475/SCH900475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for the First-line Treatment of Subjects With Extensive Stage Small Cell Lung Cancer (KEYNOTE-604)

Study ID: NCT03066778

Study Description

Brief Summary: The purpose of this study is to assess the safety and efficacy of pembrolizumab plus standard of care (SOC) chemotherapy (etoposide/platinum \[EP\]) in participants with newly diagnosed extensive stage small cell lung cancer (ES-SCLC) who have not previously received systemic therapy for this malignancy. The primary study hypotheses are that pembrolizumab+EP prolongs Progression-free Survival (PFS) per Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1 by blinded independent central review (BICR) and Overall Survival (OS) compared with placebo+EP in adult participants with ES-SCLC. In this study, RECIST 1.1 has been modified to follow a maximum of 10 target lesions and a maximum of 5 target lesions per organ. With protocol Amendment 07 (03-Oct-2018), the outcome measure of "Change from Baseline at Weeks 12 and 24 in European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) Global Health Status/Quality of Life Scale" was replaced with a single time point analysis at Week 18.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Baptist Health Medical Group Oncology, LLC ( Site 8000), Miami, Florida, United States

Rush University Medical Center ( Site 1215), Chicago, Illinois, United States

North Shore University Health System ( Site 1216), Evanston, Illinois, United States

Community Hospital ( Site 1207), Munster, Indiana, United States

Weinberg Cancer Institute at Franklin Square ( Site 1210), Baltimore, Maryland, United States

Massachusetts General Hospital ( Site 1203), Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center ( Site 1206), Boston, Massachusetts, United States

Dana-Farber Cancer Institute [Boston] ( Site 1201), Boston, Massachusetts, United States

University of Michigan ( Site 1217), Ann Arbor, Michigan, United States

Henry Ford Health System ( Site 1221), Detroit, Michigan, United States

Minnesota Oncology Hematology, PA ( Site 8001), Minneapolis, Minnesota, United States

Hattiesburg Clinic ( Site 1205), Hattiesburg, Mississippi, United States

Mercy Hospital Saint Louis ( Site 1213), Saint Louis, Missouri, United States

Comprehensive Cancer Centers of Nevada ( Site 8004), Henderson, Nevada, United States

Memorial Sloan-Kettering Cancer Center At Basking Ridge ( Site 1226), Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Cancer Center- Monmouth ( Site 1225), Middletown, New Jersey, United States

Montefiore Einstein Center for Cancer Care - Main site ( Site 1204), Bronx, New York, United States

Montefiore Medical Center ( Site 1222), Bronx, New York, United States

Memorial Sloan-Kettering Cancer Center at Commack ( Site 1227), Commack, New York, United States

Memorial Sloan Kettering Cancer Center ( Site 1229), Harrison, New York, United States

Memorial Sloan Kettering Cancer Center ( Site 1211), New York, New York, United States

Memorial Sloan Kettering Cancer Center - Rockville Centre ( Site 1228), Rockville Centre, New York, United States

Duke University Medical Center ( Site 1214), Durham, North Carolina, United States

Bon Secours St. Francis Health Sytem ( Site 1212), Greenville, South Carolina, United States

Tennessee Oncology, PLLC/The Sarah Cannon Research Institute ( Site 1230), Nashville, Tennessee, United States

Texas Oncology ( Site 8002), Austin, Texas, United States

Texas Oncology-Baylor Charles A. Sammons Cancer Center ( Site 8003), Dallas, Texas, United States

Blacktown Hospital ( Site 0004), Blacktown, New South Wales, Australia

Southern Medical Day Care Centre ( Site 0001), Wollongong, New South Wales, Australia

St John of God ( Site 0006), Murdoch, Western Australia, Australia

Lyell McEwin Hospital ( Site 0002), Elizabeth Vale, , Australia

St Vincents Hospital Melbourne ( Site 0005), Fitzroy, , Australia

Cancer Care Manitoba ( Site 0159), Winnipeg, Manitoba, Canada

Nova Scotia Health Authority ( Site 0157), Halifax, Nova Scotia, Canada

William Osler Health System (Brampton Civic Hospital) ( Site 0161), Brampton, Ontario, Canada

Kingston Health Sciences Centre ( Site 0155), Kingston, Ontario, Canada

Sunnybrook Research Institute ( Site 0151), Toronto, Ontario, Canada

CISSS de la Monteregie-Centre ( Site 0152), Greenfield Park, Quebec, Canada

CISSS-CA Hotel Dieu de Levis ( Site 0154), Lévis, Quebec, Canada

CIUSSS Ouest de l'Ile - St-Mary's Hospital ( Site 0158), Montreal, Quebec, Canada

St. Jerome Medical Research Inc. ( Site 0160), St-Jerome, Quebec, Canada

Instituto Nacional del Cancer ( Site 0207), Santiago, Region Metropolitana, Chile

Health and Care Chile ( Site 0202), Santiago, , Chile

Fundacion Arturo Lopez Perez FALP ( Site 0203), Santiago, , Chile

Pontificia Universidad Catolica de Chile ( Site 0206), Santiago, , Chile

Clinica Universidad Catolica del Maule ( Site 0208), Talca, , Chile

CHRU de Lille - Hopital Albert Calmette ( Site 0353), Lille, , France

C.H.R.U. De Limoges ( Site 0358), Limoges, , France

CHU Nantes - Hopital Laennec ( Site 0363), Nantes, , France

Centre Antoine Lacassagne ( Site 0362), Nice, , France

Hopital Tenon ( Site 0360), Paris, , France

Institut de Cancerologie Jean-Godinot ( Site 0351), Reims, , France

CHU de Toulouse - Hopital Larrey ( Site 0354), Toulouse, , France

Evangelische Lungenklinik Berlin ( Site 0403), Berlin, , Germany

Medizinische Fakultaet Carl Gustav Carus der TU Dresden ( Site 0411), Dresden, , Germany

Florence Nightingale Krankenhaus ( Site 0413), Duesseldorf, , Germany

SRH Waldklinikum Gera GmbH ( Site 0405), Gera, , Germany

Asklepios Klinikum Harburg ( Site 0412), Hamburg, , Germany

Thoraxklinik Heidelberg gGmbH am Universitaetsklinikum Heidelberg ( Site 0401), Heidelberg, , Germany

Philipps-Universitat Marburg ( Site 0414), Marburg, , Germany

Universitaetsklinikum Tuebingen ( Site 0404), Tuebingen, , Germany

Orszagos Onkologiai Intezet ( Site 0453), Budapest, Pest, Hungary

Orszagos Koranyi TBC es Pulmonologiai Intezet ( Site 0452), Budapest, , Hungary

Orszagos Koranyi TBC es Pulmonologiai Intezet ( Site 0458), Budapest, , Hungary

Orszagos Koranyi TBC es Pulmonologiai Intezet ( Site 0459), Budapest, , Hungary

Veszprem Megyei Tudogyogyintezet ( Site 0454), Farkasgyepu, , Hungary

Petz Aladar Megyei Oktato Korhaz ( Site 0460), Gyor, , Hungary

Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz ( Site 0456), Szekesfehervar, , Hungary

Jasz Nagykun Szolnok Megyei Hetenyi Geza Korhaz Rendelointezet ( Site 0451), Szolnok, , Hungary

Zala Megyei Szent Rafael Korhaz ( Site 0457), Zalaegerszeg, , Hungary

St Vincents University Hospital ( Site 1456), Dublin, , Ireland

St James Hospital ( Site 1452), Dublin, , Ireland

Soroka Medical Center ( Site 0505), Beer Sheva, , Israel

Ramban Medical Center - Dept. Hemato. & B. Marrow Transplant ( Site 0502), Haifa, , Israel

Meir Medical Center ( Site 0503), Kfar Saba, , Israel

Rabin Medical Center ( Site 0504), Petah Tikva, , Israel

Chaim Sheba Medical Center. ( Site 0501), Ramat-Gan, , Israel

National Hospital Organization Nagoya Medical Center ( Site 0615), Nagoya, Aichi, Japan

National Cancer Center Hospital East ( Site 0613), Kashiwa, Chiba, Japan

National Hospital Organization Shikoku Cancer Center ( Site 0614), Matsuyama, Ehime, Japan

Kurume University Hospital ( Site 0609), Kurume, Fukuoka, Japan

Hyogo Cancer Center ( Site 0611), Akashi, Hyogo, Japan

Kanagawa Cancer Center ( Site 0618), Yokohama, Kanagawa, Japan

Sendai Kousei Hospital ( Site 0602), Sendai, Miyagi, Japan

National Hospital Organization Kinki-chuo Chest Medical Center ( Site 0608), Sakai, Osaka, Japan

Shizuoka Cancer Center Hospital and Research Institute ( Site 0607), Sunto-gun, Shizuoka, Japan

National Hospital Organization Yamaguchi Ube Medical Center ( Site 0601), Ube, Yamaguchi, Japan

National Hospital Organization Kyushu Medical Center ( Site 0617), Fukuoka, , Japan

Hiroshima University Hospital ( Site 0604), Hiroshima, , Japan

Niigata Cancer Center Hospital ( Site 0610), Niigata, , Japan

Osaka International Cancer Institute ( Site 0616), Osaka, , Japan

The Cancer Institute Hospital of JFCR ( Site 0606), Tokyo, , Japan

Wakayama Medical University Hospital ( Site 0612), Wakayama, , Japan

Inje University Haeundae Paik Hospital ( Site 0905), Busan, , Korea, Republic of

National Cancer Center ( Site 0904), Goyang-si, , Korea, Republic of

Severance Hospital Yonsei University Health System ( Site 0903), Seoul, , Korea, Republic of

Asan Medical Center ( Site 0901), Seoul, , Korea, Republic of

Samsung Medical Center ( Site 0902), Seoul, , Korea, Republic of

Canterbury Regional Cancer & Blood Services ( Site 0701), Christchurch, , New Zealand

Mazowiecki Szpital Onkologiczny ( Site 0757), Wieliszew, Mazowieckie, Poland

Przychodnia Lekarska Komed ( Site 0769), Konin, , Poland

Krakowski Szpital Specjalistyczny im. Jana Pawla II ( Site 0768), Krakow, , Poland

Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli ( Site 0767), Lublin, , Poland

SKPP UM im. Karola Marcinkowkiego w Poznaniu ( Site 0766), Poznan, , Poland

Wielkopolskie Centrum Pulmonologii i Torakochirurgii ( Site 0762), Poznan, , Poland

Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu ( Site 0756), Torun, , Poland

Centrum Onkologii-Instytut im. Marii Sklodowskiej-Curie ( Site 0751), Warszawa, , Poland

Dolnoslaskie Centrum Onkologii we Wroclawiu ( Site 0771), Wroclaw, , Poland

Belgorod Regional Oncology Dispensary ( Site 0804), Belgorod, , Russian Federation

N.N. Blokhin NMRCO ( Site 0801), Moscow, , Russian Federation

SBI of Stavropol region Pyatigorskiy Oncologic dispensary ( Site 0811), Pyatigorsk, , Russian Federation

SBHI Leningrad Regional Clinical Hospital ( Site 0803), Saint Petersburg, , Russian Federation

Municipal Clinical Oncology Center ( Site 0802), Saint Petersburg, , Russian Federation

Hospital Universitario Insular de Gran Canaria ( Site 0952), Las Palmas de Gran Canaria, Gran Canaria, Spain

Complejo Hospitalario Universitario de A Coruna ( Site 0953), A Coruna, , Spain

Hospital del Mar ( Site 0956), Barcelona, , Spain

Hospital Universitari Vall d Hebron ( Site 0951), Barcelona, , Spain

Hospital Ciudad de Jaen ( Site 0957), Jaen, , Spain

Hospital General Universitario Gregorio Maranon ( Site 0958), Madrid, , Spain

Hospital Universitario Fundacion Jimenez Diaz ( Site 0954), Madrid, , Spain

Hospital Clinico Universitario de Valencia ( Site 0955), Valencia, , Spain

Kantonsspital Graubuenden ( Site 1403), Chur, , Switzerland

CHUV Centre Hospitalier Universitaire Vaudois ( Site 1405), Lausanne, , Switzerland

Universitaetsspital Zuerich ( Site 1404), Zuerich, , Switzerland

Kaohsiung Chang Gung Memorial Hospital of the C.G.M.F. ( Site 1005), Kaohsiung, , Taiwan

China Medical University Hospital. ( Site 1003), Taichung, , Taiwan

Taichung Veterans General Hospital ( Site 1007), Taichung, , Taiwan

National Cheng Kung University Hospital ( Site 1004), Tainan, , Taiwan

Chi Mei Medical Center Liuying ( Site 1006), Tainan, , Taiwan

National Taiwan University Hospital ( Site 1001), Taipei, , Taiwan

Taipei Veterans General Hospital ( Site 1002), Taipei, , Taiwan

Ege Universitesi Tıp Fakultesi ( Site 1052), Izmir, Bornova, Turkey

Baskent University Adana Dr. Turgut Noyan EAH ( Site 1057), Adana, , Turkey

Ankara UTF ( Site 1055), Ankara, , Turkey

Hacettepe Universitesi Tip Fakultesi Hastanesi ( Site 1060), Ankara, , Turkey

Dr. Abdurrahman Yurtaslan Ankara Onkoloji EAH ( Site 1053), Ankara, , Turkey

Trakya Uni. Tip Fakultesi ( Site 1063), Edirne, , Turkey

Istanbul Universitesi Cerrahpasa Tip Fakultesi ( Site 1058), Istanbul, , Turkey

Medipol Hastanesi ( Site 1066), Istanbul, , Turkey

Medeniyet Uni. Goztepe Egitim ve Arast. Hast. ( Site 1064), Istanbul, , Turkey

Medical Park Izmir Hospital ( Site 1051), Izmir, , Turkey

Kocaeli Universitesi Tip Fakultesi ( Site 1061), Kocaeli, , Turkey

Inonu Universitesi Tip Fakultesi ( Site 1059), Malatya, , Turkey

Birmingham Heartlands Hospital ( Site 1162), Birmingham, , United Kingdom

St James s University Hospital ( Site 1161), Leeds, , United Kingdom

North Middlesex Hospital ( Site 1151), London, , United Kingdom

Maidstone Hospital ( Site 1155), Maidstone, , United Kingdom

Mount Vernon Cancer Centre ( Site 1156), Northwood, , United Kingdom

Contact Details

Name: Medical Director

Affiliation: Merck Sharp & Dohme LLC

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: